Esperion — Drug Prices & Medicare Spending
Esperion manufactures 2 drugs tracked by Medicare Part D with total spending of $412.0M.
2
Drugs Tracked
$412.0M
Medicare Spending
$276.88
Avg Cost/Claim
100%
Have Generics
Esperion Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Nexletol | Bempedoic Acid | $271.00 | Yes |
| 2 | Nexlizet | Bempedoic Acid/Ezetimibe | $285.00 | Yes |
Frequently Asked Questions
Esperion manufactures 2 drugs tracked by Medicare Part D, with total annual spending of $412.0M.
Nexlizet (Bempedoic Acid/Ezetimibe) is the most expensive at $285.00 per claim.
2 of 2 Esperion drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.